Proteomic analysis of brain proteins in APP/PS‐1 human double mutant knock‐in mice with increasing amyloid β‐peptide deposition: Insights into the effects of in vivo treatment with N‐acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Proteomics

• Publication date

  2011-09-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pmic.201000523PMID 21954051PMCID PMC3517055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The oxidative stress hypothesis in Alzheimer's disease.

  2013cited by this paper
• Proteomics

  2011cited by this paper
• Potential in vivo amelioration by N‐acetyl‐L‐cysteine of oxidative stress in brain in human double mutant APP/PS‐1 knock‐in mice: Toward therapeutic modulation of mild cognitive impairment

  2010influential reference
• Redox proteomics identification of 4‐hydroxynonenal‐modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis

  2009cited by this paper
• Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis

  2009cited by this paper
• Prohibitin is a novel regulator of antioxidant response that attenuates colonic inflammation in mice.

  2009cited by this paper
• Proteomic identification of nitrated brain proteins in early Alzheimer’s disease inferior parietal lobule

  2009cited by this paper
• Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age.

  2008cited by this paper
• Interleukin-1β-dependent Signaling between Astrocytes and Neurons Depends Critically on Astrocytic Calcineurin/NFAT Activity*

  2008cited by this paper
• Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid beta-peptide.

  2008cited by this paper
• Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

  2007cited by this paper
• Prolyl cis-trans isomerization as a molecular timer.

  2007cited by this paper
• Proteomics Analysis of the Alzheimer's Disease Hippocampal Proteome

  2007cited by this paper
• Prohibitin protects against oxidative stress in intestinal epithelial cells

  2007cited by this paper
• Redox Proteomics Identification of Oxidatively Modified Brain Proteins in Alzheimer's Disease and Mild Cognitive Impairment: Insights into the Progression of this Dementing Disorder

  2007cited by this paper
• Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice.

  2007cited by this paper
• The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production

  2007cited by this paper
• Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

  2007cited by this paper
• Aβ solubility and deposition during AD progression and in APP × PS-1 knock-in mice

  2007cited by this paper
• Quantitative proteomics analysis of differential protein expression and oxidative modification of specific proteins in the brains of old mice.

  2006cited by this paper
• Mutations in amyloid precursor protein and presenilin‐1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid β‐peptide (1–42), H2O2 and kainic acid: implications for Alzheimer's disease

  2006cited by this paper
• Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis.

  2006cited by this paper
• Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.

  2006cited by this paper
• β-Amyloid Mediated Nitration of Manganese Superoxide Dismutase: Implication for Oxidative Stress in a APPNLh/NLh X PS-1P264L/P264L Double Knock-In Mouse Model of Alzheimer's Disease

  2006cited by this paper
• The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production

  2006cited by this paper
• Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.

  2006cited by this paper
• REVIEW: Pin1 in Alzheimer's disease

  2006cited by this paper
• Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: An initial assessment

  2006cited by this paper
• Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.

  2006cited by this paper
• Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease

  2005cited by this paper
• Proteomic identification of differentially expressed proteins in the aging murine olfactory system and transcriptional analysis of the associated genes

  2005cited by this paper
• [At the boundary between normal aging and Alzheimer disease].

  2004cited by this paper
• Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins.

  2004cited by this paper
• Aux frontières de l’Alzheimer

  2004cited by this paper
• The antioxidants α‐lipoic acid and N‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice

  2003cited by this paper
• Neuronal and glial calcium signaling in Alzheimer's disease.

  2003cited by this paper
• Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease.

  2003cited by this paper
• Alzheimer disease in the US population: prevalence estimates using the 2000 census.

  2003cited by this paper
• Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies.

  2003cited by this paper
• Protein abundance quantification in embryonic stem cells using incomplete metabolic labelling with 15N amino acids, matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry, and analysis of relative isotopologue abundances of peptides.

  2003cited by this paper
• Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions.

  2003cited by this paper
• Understanding ATP synthesis: structure and mechanism of the F1-ATPase (Review).

  2003cited by this paper
• Differential Regulation of Glutamate Receptors in Alzheimer’s Disease

  2002cited by this paper
• Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.

  2002cited by this paper
• The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease

  2002cited by this paper
• Disruption of neurogenesis by amyloid β‐peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease

  2002cited by this paper
• Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

  2002cited by this paper
• Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress

  2002cited by this paper
• Nutritional approaches to combat oxidative stress in Alzheimer's disease.

  2002cited by this paper
• Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence.

  2001cited by this paper
• Traumatic Brain Injury-Induced Changes in Gene Expression and Functional Activity of Mitochondrial Cytochrome C Oxidase

  2001cited by this paper
• The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

  2001cited by this paper
• Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

  2001influential reference
• Role of Free Radicals in the Neurodegenerative Diseases

  2001cited by this paper
• Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease.

  2001cited by this paper
• Calcineurin Links Ca2+ Dysregulation with Brain Aging

  2001cited by this paper
• Prohibitins act as a membrane‐bound chaperone for the stabilization of mitochondrial proteins

  2000cited by this paper
• Presenilin-1 P264L Knock-In Mutation: Differential Effects on Aβ Production, Amyloid Deposition, and Neuronal Vulnerability

  2000cited by this paper
• N‐acetyl‐L‐cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis

  2000cited by this paper
• Phosphorylation-dependent prolyl isomerization: a novel cell cycle regulatory mechanism.

  2000cited by this paper
• In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain.

  2000cited by this paper
• Effect of Exogenous and Endogenous Antioxidants on 3‐Nitropionic Acid‐Inducedin vivo Oxidative Stress and Striatal Lesions

  2000cited by this paper
• Mild cognitive impairment: transition between aging and Alzheimer's disease.

  2000cited by this paper
• Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.

  2000cited by this paper
• Increased DNA Oxidation and Decreased Levels of Repair Products in Alzheimer's Disease Ventricular CSF

  1999cited by this paper
• RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

  1999cited by this paper
• In vivo modulation of rodent glutathione and its role in peroxynitrite-induced neocortical synaptosomal membrane protein damage.

  1999cited by this paper
• Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.

  1998cited by this paper
• Glutathione Therapy: From Prodrugs to Genes

  1998cited by this paper
• The free radical theory of aging matures.

  1998cited by this paper
• Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

  1997cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease.

  1997influential reference
• A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

  1997cited by this paper
• Enhanced Amyloidogenic Processing of the β-Amyloid Precursor Protein in Gene-targeted Mice Bearing the Swedish Familial Alzheimer's Disease Mutations and a “Humanized” Aβ Sequence*

  1996cited by this paper
• Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

  1996cited by this paper
• Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

  1996cited by this paper
• Are reactive oxygen species involved in Alzheimer's disease?

  1995cited by this paper
• Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study.

  1994cited by this paper
• Oxidative damage to mitochondrial DNA shows marked age‐dependent increases in human brain

  1993cited by this paper
• Role of Synaptosomal Enzymatic Alterations and Drug Treatment in Brain Aging

  1990cited by this paper
• Age‐related modification of enzyme activities in synaptosomes isolated from rat cerebral cortex

  1989cited by this paper
• Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine.

  1977cited by this paper
• Neurobiology of Aging Xxx (2005) Xxx–xxx

  year unknowncited by this paper

• Mitochondria-targeting by small molecules against Alzheimer's disease: A mechanistic perspective.

  2024cites this paper
• Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.

  2024cites this paper
• UBQLN1 links proteostasis and mitochondria function to telomere maintenance in human embryonic stem cells

  2024cites this paper
• Evaluation of the potential of N-acetylcysteine in Alzheimer's disease

  2023cites this paper
• The effect of NAC and Carnosine on alzheimer’s disease-related in vitro model through RAGE-AGE signaling pathway

  2023cites this paper
• Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment

  2023cites this paper
• Mitochondrial mechanisms in Alzheimer's disease: quest for therapeutics.

  2023cites this paper
• N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy

  2021cites this paper
• Strategies to protect against age-related mitochondrial decay: Do natural products and their derivatives help?

  2021cites this paper
• An insight on safety, efficacy, and molecular docking study reports of N-acetylcysteine and its compound formulations

  2021cites this paper
• Changes in the expression of the B subunit of vacuolar H+-ATPase, in the hippocampus, following transient forebrain ischemia in gerbils.

  2021cites this paper
• BRAIN LIPID PEROXIDATION AND ALZHEIMER DISEASE: SYNERGY BETWEEN THE BUTTERFIELD AND MATTSON LABORATORIES.

  2020cites this paper
• Supplementation with γ-glutamylcysteine (γ-GC) lessens oxidative stress, brain inflammation and amyloid pathology and improves spatial memory in a murine model of AD.

  2020cites this paper
• The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.

  2019cites this paper
• The Isoquinoline Alkaloid Dauricine Targets Multiple Molecular Pathways to Ameliorate Alzheimer-Like Pathological Changes In Vitro

  2018cites this paper
• Selenium positively affects the proteome of 3 × Tg‐AD mice cortex by altering the expression of various key proteins: unveiling the mechanistic role of selenium in AD prevention

  2018cites this paper
• Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease

  2018cites this paper
• Nutrition and Alzheimer Disease.

  2018cites this paper
• RyR2-Mediated Ca2+ Release and Mitochondrial ROS Generation Partake in the Synaptic Dysfunction Caused by Amyloid β Peptide Oligomers

  2017cites this paper
• The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics

  2017cites this paper
• Electrochemical Detection of Plasma Immunoglobulin as a Biomarker for Alzheimer’s Disease

  2017cites this paper
• Identification of Novel Key Molecules Involved in Spatial Memory Impairment in Triple Transgenic Mice of Alzheimer’s Disease

  2016cites this paper
• An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.

  2016cites this paper
• Proteomic analysis of hippocampus in mice following long-term exposure to low levels of copper.

  2016cites this paper
• Novel therapy of hyperhomocysteinemia in mild cognitive impairment, Alzheimer's disease, and other dementing disorders

  2016cites this paper
• Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase

  2016cites this paper
• An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.

  2016cites this paper
• The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial

  2016cites this paper
• Mass Spectrometry-Based Investigation of APP-Dependent Mechanisms in Neurodegeneration

  2015cites this paper
• Identification of the Key Molecules Involved in Chronic Copper Exposure-Aggravated Memory Impairment in Transgenic Mice of Alzheimer's Disease Using Proteomic Analysis

  2015cites this paper
• Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.

  2015cites this paper
• Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease

  2015cites this paper
• Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants

  2015cites this paper
• Global cPILOT analysis of the APP/PS‐1 mouse liver proteome

  2015cites this paper
• Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?*

  2015cites this paper
• Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases

  2015cites this paper
• Multiplexing Techniques in Quantitative Proteomics to Study Disease

  2015cites this paper
• THERMAL DEGRADATION OF AMINES FOR CO 2 CAPTURE

  2015cites this paper
• Proteomic response to metabolic stress and cellular dysfunction in relation to Alzheimer's disease

  2014cites this paper
• An open‐label pilot study of N‐acetylcysteine for skin‐picking in Prader–Willi syndrome

  2014cites this paper
• Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.

  2014cites this paper
• Proteomic Analysis of Serum Proteins in Triple Transgenic Alzheimer's Disease Mice: Implications for Identifying Biomarkers for Use to Screen Potential Candidate Therapeutic Drugs for Early Alzheimer's Disease

  2014cites this paper
• The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

  2014cites this paper
• Mitigating Oxidative Stress in Childhood Cerebral Adrenoleukodystrophy -An Investigation of N-acetylcysteine Pharmacology

  2014cites this paper
• The 2013 Discovery Award from the Society for Free Radical Biology and Medicine : Selected Discoveries from the Butterfield Laboratory of Oxidative Stress and Its Sequelae in Brain in Cognitive Disorders Exemplified by Alzheimer Disease and Chemotherapy Induced Cognitive Impairment

  2014cites this paper
• Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants.

  2013cites this paper
• Characterizing N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) binding for lead poisoning treatment.

  2012cites this paper
• Antioxidants as Antidepressants

  2012cites this paper
• Thinking Outside the Cleft to Understand Synaptic Activity: Contribution of the Cystine-Glutamate Antiporter (System xc−) to Normal and Pathological Glutamatergic Signaling

  2012influential citation
• 2011 Annual Report

  2011cites this paper